Heritability and pharmacogenetics in patients with type 2 diabetes

Kaixin's Fellowship will focus on developing statistical and computational tools for pharmacogenetics and pharmacogenomic studies, to uncover the genes influencing drug efficacy and adverse effects. In particular, he will develop methods to address the challenge in clinical datasets of observational and longitudinal nature and apply them to the studies of type 2 diabetes pharmacogenetics in the Diabetes Audit and Research Tayside Study (DARTS) cohort.